Contact us
한국어
About
Mission Message
Introduction
Collaborating Partners
Governance
Council
Board of Directors
Selection Committee
Management Team
Investment
Investment Principles
Investment Area
Investment Priorities
Investment Process
Portfolio
Global Access Policy
News
Press Releases
News & Event
Publications
Newsletter
Media Guidelines
Notice
Notice
Careers
Contacts & Inquiry
Apply for Funding
Funding Opportunities
Apply for Product Development Award
Apply for Evidence Generation Award
RFP FAQ
✕
Featured News: The key of new single-dose antimalarial drug is a Continuous Process Development
Home
News & Event
Featured News: The key of new single-dose antimalarial drug is a Continuous Process Development
Featured News: Supply of hexavalent vaccines to developing countries could completely eradicate polio
2020년 February 21일
Featured News: New Diagnostic For Safe Administration of Malaria Drugs…Screening For G6PD Deficiency
2020년 February 26일
2020년 February 23일
Categories
News & Event
Tags
PPublished in the The DOCTOR’S NEWS
This article is only available in Korean.
Original Article
Share
Related posts
2022년 December 14일
South Korean partners come together at the re-imagining TB initiative’s first collaboration workshop
Read more
2022년 July 13일
Featured News: RIGHT Fund to receive research proposals for infectious disease
Read more
2022년 April 18일
Interview: Peter Hotez, Director of the RIGHT Fund “Inequity, the hidden super transmitter of COVID-19”
Read more
Contents in Preparation
×
